Infantile Spasm Treatment Market Analysis By Product Type (Vigabatrin, Adrenocorticotropic Hormone, Phase III), By Route of Administration(Oral, Parenteral, Others) & Forecast
- PUBLISHED ON
- 24/03/2023
- NO OF PAGES
- 265
- CATEGORY
- Healthcare & Life Sciences
An infantile spasm, also called as a West syndrome, is an unusual seizure disorder that happens in an epilepsy syndrome of infancy and childhood. The beginning of infantile spasm usually happens in the first year of life between four months and eight months of age. The illness is usually witnessed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life. Nearly 2,000-4,000 new cases are recognized in the U.S. yearly. Approximately 50%-70% of infantile spasms patients are impacted by other types of seizures, although almost 18%-50% grow either Lennox-Gastaut syndrome or other forms of symptomatic generalized epilepsy. There are only two FDA-approved medical treatment options accessible in the market-adrenocorticotropic hormone and vigabatrin.
The growing scientific advancements in the treatment for infantile spasms are the major factor that contributes to the market growth. For instance, due to advancements in technology, a seizure alert device has been developed that helps discover seizures and warns the physician through phone calls, alarms, or text messages. These innovations aid in early diagnosis by physicians, which surges the life expectation of patients. Exact diagnosis of infantile spasms benefits the physician make precise decisions to recommend a suitable treatment regimen, thus enlightening the efficacy of the treatment. These innovative technologies also help reduce the undiagnosed population, thereby enhancing the penetration rate of infantile spasm drugs. Furthermore, there are various awareness programs conducted by the government and private organizations to decrease the number of undiagnosed cases. Nevertheless, factors such as low success rate could hinder the growth of the infantile spasms treatment market.
The coronavirus (COVID-19) pandemic has diseased nearly every business in the world, containing machinery manufacturing. Numerous countries such as India, Italy, and China have enforced national lockdowns to combat the COVID-19 pandemic, enabling it in stages and over industry. This has ensured a major consequence on machinery manufacturing, as factories all across the world have been momentarily shut down.
Route of Administration Insights
Based on the route of administration, the global infantile spasm treatment market is bifurcated into oral, parenteral, others. The parenteral segment accounted for the maximum market share throughout the forecasted period and will continue to dominate the infantile spasms therapeutics market. The key provider to this governance is the inclination of this method of drug administration by physicians when continued action of the drug is necessary. In the parenteral ROA, the drugs are usually managed via subcutaneous, intravenous, intrathecal, or intramuscular routes; drugs provided via this route are immersed rapidly, and the onset of action is fast. This factor will upsurge the infantile spasms treatment market size.
Region Insights
North America holds important position in the global infantile spasm treatment market, owing to growing adoption of infantile spasms treatment procedures and large scale research and development activities in this area. For instance, INSYS Therapeutics developed Cannabidiol, Oral Solution for infantile spasm that is in phase III clinical trial. The reoccurrence of infantile spasm is a major part that upsurges the market growth.
Asia-Pacific is anticipated to grow during the forecast period owing to the growing research and development investments, increasing investment in the healthcare sector, existence of large target patient pool, upsurge in the disposable income and increasing government support.
Key Companies Insights
The market for infantile spasm treatment is moderately competitive. With the rising applications of infantile spasm treatment, new players are considering to enter the market. The companies are also involved in events like acquisitions, joint ventures, partnerships, mergers, and collaborations. These activities aid in growing the effect of the players in the infantile spasm treatment market, ultimately boosting the market growth.
• H. Lundbeck A/S
• Mallinckrodt Pharmaceuticals
• Catalyst Pharmaceuticals
• GW Pharmaceuticals plc
• Retrophin, Inc.
• Valerion Therapeutics
• Orphelia Pharma SA
• Insys Therapeutics, Inc.
• Anavex Life Sciences Corp.
• Other players
Some of the Recent Developments:
• In October 2012, INSYS Therapeutics manufactured Cannabidiol, Oral Solution for infantile spasm, which is under phase III clinical trial. The reoccurrence of infantile spasm is a major feature that boosts the market growth.
Segments
By Product Type
• Vigabatrin
• Adrenocorticotropic Hormone
• Phase III
By Route of Administration
• Oral
• Parenteral
• Others
By Geography
• North America
o U.S.
o Canada
o Mexico
• Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o ASEAN
• Latin America
o Brazil
o Argentina
o Colombia
• MEA
o South Africa
o Saudi Arabia
o UAE
o Egypt
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.
}})
Select a license type that suits your business needs
US $4250
Only Four Thousand Two Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $5250
Only Five Thousand Two Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $6250
Only Six Thousand Two Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI